PDB16 Treated to Glycemic Control Target Assessed by Fasting Plasma Glucose (Fpg) and Glycated Hemoglobin (Hba1C) in Patients With Type II Diabetes
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.937
https://www.valueinhealthjournal.com/article/S1098-3015(12)01002-9/fulltext
Title :
PDB16 Treated to Glycemic Control Target Assessed by Fasting Plasma Glucose (Fpg) and Glycated Hemoglobin (Hba1C) in Patients With Type II Diabetes
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01002-9&doi=10.1016/j.jval.2012.03.937
First page :
A173
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
434